K2X Technology & Life Science, Inc.
KBPH
OTC PK
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Net Income | 1,420.49% | 570.44% | 121.63% | 155.21% | 82.34% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -207.33% | -357.02% | -1,856.50% | -1,816.11% | -1,266.57% |
| Change in Net Operating Assets | -0.30% | -205.24% | -100.74% | -40.87% | -272.53% |
| Cash from Operations | -11.47% | -168.13% | -100.58% | -28.02% | -214.23% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 151.92% | 100.00% | 28.09% |
| Total Debt Issued | -257.14% | -283.33% | -- | -- | 75.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -91.73% | -- | -- | -- | 31,863.27% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 95.13% | 52.86% | 79.75% | 23.13% | -10.56% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -83.44% | -- | -- | -- | 185.79% |
| Cash from Financing | 8.41% | 143.13% | 202.08% | 107.19% | 88.06% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -69.42% | -156.42% | 278.58% | 2,448.16% | -64.08% |
